Anti-HIF-1 alpha 抗体 [EP1215Y]
Anti-HIF-1 alpha antibody [EP1215Y]
- KO Validated
- RabMAb
- Advanced Validation
- Recombinant
- 詳細を見る
4
(15 Reviews)
|
(450 Publications)
Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) is a rabbit monoclonal antibody detecting HIF-1 alpha in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, IHC-P, ICC/IF. Suitable for Human.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 340 publications
- Trusted since 2007
別名を表示する
BHLHE78, MOP1, PASD8, HIF1A, Hypoxia-inducible factor 1-alpha, HIF-1-alpha, HIF1-alpha, ARNT-interacting protein, Basic-helix-loop-helix-PAS protein MOP1, Class E basic helix-loop-helix protein 78, Member of PAS protein 1, PAS domain-containing protein 8, bHLHe78
- WB
Lab
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
Western blot : Anti-HIF1A antibody [EP1215Y] (ab51608) staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab51608 was shown to bind specifically to HIF1A. A band was observed at 105 kDa in wild-type Wild-type HCT 116 DMOG (0 mM, 4 h) cell lysates with no signal observed at this size in HIF1A knockout cell line. To generate this image, wild-type and HIF1A knockout Wild-type HCT 116 DMOG (0 mM, 4 h) cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) at 1/1000 dilution
Lane 1:
Wild-type HCT116 DMOG (0 mM, 4 h) cell lysate at 20 µg
Lane 2:
Wild-type HCT116 treated DMOG (1 mM, 4 h) cell lysate at 20 µg
Lane 3:
HIF1A knockout HCT116 DMOG (0 mM, 4 h) cell lysate at 20 µg
Lane 4:
HIF1A knockout HCT116 treated DMOG (1 mM, 4 h) cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 105 kDa
false
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
ab51608 staining HIF-1-alpha in HeLa cell line treated with Cocl2 by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with 4% Paraformaldehyde permeabilized with 0.1% Triton X-100. Samples were incubated with primary antibody (1/500). An Alexa Fluor® 488-conjugated Goat anti-rabbit IgG(1/200) was used as the secondary antibody. Nuclei were counterstained with DAPI(right hand image).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
HeLa cells were untreated or treated with 1mM Deferoxamine (DFO) for 24h and fixed with paraformaldehyde for imaging by fluorescent microscopy. Cells were blocked and stained with 1X blocking buffer (ab126587). Unpurified ab51608 was used at 1 : 500. DAPI was used to label the nucleus. HIF1 alpha staining is absent in untreated cells and induced by DFO treatment. HIF1 alpha localizes to the nucleus.
- IHC-P
PubMed
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
Immunohistochemical analysis of Formalin-fixed paraffin-embedded human CRC tumour tissue using ab51608 for HIF-1 alpha staining. Endogenous peroxidase of sections was inhibited by 7.5% H2O2 at room temperature
In central tumor areas of human CRCs β-catenin was typically localized at the cell membrane (A) whereas only a weak staining was observed for cytoplasmic GRP78 (B) and HIF-1 alpha staining was found to be negative (C). At the invasion front strong nuclear β-catenin was detectable indicating EMT (D, G). In corresponding regions strong cytoplasmic GRP78 expression was found (E, H). In some of the cases an intense nuclear HIF-1 alpha staining was observed (F, with hypoxia), but not in others (I, without hypoxia) (magnification 200×; scale bar : 100 μm).
Image from Zeindl-Eberhart E et al. Epithelial-mesenchymal transition induces endoplasmic-reticulum-stress response in human colorectal tumor cells. PLoS One 9:e87386 (2014).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
Unpurified ab51608 staining HIF-1-alpha in HepG2 cells treated with baicalein (ab120723), by ICC/IF. Increase in HIF-1-alpha expression correlates with increased concentration of baicalein as described in literature.
The cells were incubated at 37°C for 6h in media containing different concentrations of ab120723 (baicalein) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab51608 (5 μg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody.
- IHC-P
PubMed
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
Immunohistochemical analysis of paraffin-embedded formalin-fixed human gastric cancer tissue stained for HIF-1 alpha using ab15608 at 1/600 dilution. Tissue sections were counterstained with Mayer's hematoxylin. Citrate buffer (pH 6.0) antigen retrieval using standard methodology
C. HIF-1 alpha was located mainly in the nucleus of tumor cells (positive expression ×400).
D. HIF-1 alpha original magnification ×100.
Image from Chen L et al. HIF-1 alpha overexpression correlates with poor overall survival and disease-free survival in gastric cancer patients post-gastrectomy. PLoS One 9:e90678 (2014).
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
Flow cytometry overlay histogram showing left, HeLa treated with 1mM Deferoxamine for 24h and right, negative untreated HeLa stained with ab51608 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilised with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interaction followed by the antibody (ab51608) (1x 106 in 100μl at 0.2μg/ml (1/11000)) for 30min at 22°C.
The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min at 22°C
Isotype control antibody (black line) was Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control.
Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.
This antibody gave a positive signal in HeLa Fixed with 4% formaldehyde (10 min) / permeabilised with 0.1% PBS-Triton X-100 for 15 min under the same conditions.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
Overlay histogram showing HeLa untreated (Blue line) and HeLa treated (Red line - Deferoxamine, 1mM, 24 hours) cells stained with ab51608. The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab51608, 1/11709 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluorr®488 goat anti-rabbit IgG (H&L) (ab150081) at 1/2000 dilution for 30 min at 22°C.
Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
ab51608 staining HIF-1-alpha in Human ovarian carcinoma tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed and paraffin-embedded, antigen retrieval was by heat mediation in Tris/EDTA buffer pH9. Samples were incubated with primary antibody (1/100). An undiluted HRP-conjugated anti-rabbit IgG was used as the secondary antibody. Tissue counterstained with Hematoxylin.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
ab51608 staining of HIF-1-alpha in untreated HeLa cell line by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with 4% Paraformaldehyde permeabilized with 0.1% Triton X-100. Samples were incubated with primary antibody (1/500). An Alexa Fluor® 488-conjugated Goat anti-rabbit IgG(1/200) was used as the secondary antibody. Nuclei were counterstained with DAPI(right hand Image).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
Immunohistochemical analysis using unpurified ab51608 showing positive staining in Squamous cell cervical carcinoma tissue. Heat mediated antigen retrieval was performed via the microwave method before commencing with IHC staining protocol.
- IP
Lab
Immunoprecipitation - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
HIF-1-alpha was immunoprecipitated using 0.5mg HeLa Nuclear DFO treated whole cell extract (ab180880), 5μg of Rabbit polyclonal to HIF1 alpha and 50μl of protein G magnetic beads (+). No antibody was added to the control (-).
The antibody was incubated under agitation with Protein G beads for 10min, HeLa DFO treated whole cell extract lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.
Proteins were eluted by addition of 40μl SDS loading buffer and incubated for 10min at 70°C; 10μl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with unpurified ab51608.
Secondary : Mouse monoclonal [SB62a] Secondary Antibody to Rabbit IgG light chain (HRP) (ab99697).
Band : 110kDa; HIF1 alpha
All lanes:
Immunoprecipitation - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
Predicted band size: 92 kDa
Observed band size: 110 kDa
true
Exposure time: 12min
- WB
AbReview37947****
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
Blocking buffer : 5% milk for 16 hours at 4°C.
All lanes:
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) at 1/2000 dilution
Lane 1:
MCF-7 (normoxia) at 30000 Cells
Lane 2:
MCF-7 treated with 0.5% oxygen for 24 hours at 30000 Cells
Secondary
All lanes:
Polyclonal Swine anti-rabbit IgG HRP at 1/1000 dilution
Predicted band size: 92 kDa
false
This image is courtesy of an anonymous abreview.
- WB
Unknown
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
Abcam recommends using 5% milk as the blocking agent, decreasing to 2% milk during primary and secondary incubation. Abcam welcomes customer feedback and would appreciate any comments regarding this product and the data presented above.
All lanes:
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) at 1/2000 dilution
Lane 1:
Western blot - HeLa nuclear extract lysate (<a href='/products/tissue-lysates/hela-nuclear-extract-lysate-ab150036'>ab150036</a>) at 40 µg
Lane 2:
Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (<a href='/products/tissue-lysates/hela-dfo-treated-05mm-24h-nuclear-lysate-ab180880'>ab180880</a>) at 40 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/10000 dilution
Predicted band size: 92 kDa
Observed band size: 110 kDa
true
Exposure time: 8min
- WB
Collaborator
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
Anti-HIF-1-alpha unpurified antibody (ab51608) reactivity with reduced Hep3B cell lysate after transient transfection of scrambled siRNA (lanes1-3 and 7-9) or HIF-1-alpha siRNA (lanes 4-6 and 10-12). Cells were incubated at with 21% O2 (lanes 1-6) or 1% O2 (lanes 7-12) for 4h before lysis. After SDS-PAGE, membranes were blocked in 5% milk for 1h at 25°C before incubation with unpurified ab51608 (1/1,000 dilution 5% milk) for 16h at 4°C. The blot was then incubated with an anti-Rabbit HRP-conjugated secondary antibody before developing with ECL.
All lanes:
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
Predicted band size: 92 kDa
Observed band size: ~120 kDa
true
Exposure time: 6min
Image courtesy of Teresa Otto (University of Duisburg-Essen, Germany)
- WB
Lab
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
Western blot : Anti-HIF1A antibody [EP1215Y] (ab51608) staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab51608 was shown to bind specifically to HIF1A. A band was observed at 100 kDa in wild-type HCT 116 cell lysates with no signal observed at this size in HIF1A knockout cell line. To generate this image, wild-type and HIF1A knockout HCT 116 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) at 1/1000 dilution
Lane 1:
Wild-type HCT 116 DMOG (0 mM, 4 h) nuclear cell lysate at 20 µg
Lane 2:
Wild-type HCT 116 treated DMOG (1 mM, 4 h) nuclear cell lysate at 20 µg
Lane 3:
HIF1A knockout HCT 116 DMOG (0 mM, 4 h) nuclear cell lysate at 20 µg
Lane 4:
HIF1A knockout HCT 116 treated DMOG (1 mM, 4 h) nuclear cell lysate at 20 µg
Lane 5:
Wild-type HCT 116 DMOG (0 mM, 4 h) cell lysate at 20 µg
Lane 6:
Wild-type HCT 116 treated DMOG (1 mM, 4 h) cell lysate at 20 µg
Lane 7:
HIF1A knockout HCT 116 DMOG (0 mM, 4 h) cell lysate at 20 µg
Lane 8:
HIF1A knockout HCT 116 treated DMOG (1 mM, 4 h) cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 100 kDa
false
- WB
Lab
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
Abcam recommends using 5% milk as the blocking agent, decreasing to 2% milk during primary and secondary incubation. Abcam welcomes customer feedback and would appreciate any comments regarding this product and the data presented above.
All lanes:
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) at 1/2000 dilution
Lane 1:
HeLa Whole Cell Lysate (untreated, negative control) at 40 µg
Lane 2:
HeLa DFO treated (0.5mM, 24h) Whole Cell Lysate at 40 µg
Lane 3:
HeLa Nuclear Cell Lysate (untreated, negative control) at 40 µg
Lane 4:
HeLa Nuclear DFO treated (0.5mM, 24h) Cell Lysate at 40 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/10000 dilution
Predicted band size: 92 kDa
Observed band size: 110 kDa
false
Exposure time: 2min
- WB
Lab
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
ab308433 1/1000 ab181602 1/1000000 Blocking/Diluting buffer and concentration : 5% NFDM/TBST Compared with ab51608, ab308433 has higher sensitivity, we recommend ab308433 as an alternative for testing HIF-1 alpha in western blot.
Lanes 1 - 4:
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
Lanes 1 - 4:
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] - BSA and Azide free (<a href='/products/primary-antibodies/hif-1-alpha-antibody-ep1215y-bsa-and-azide-free-ab210073'>ab210073</a>)
Lanes 1 and 3:
Untreated HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa treated with 0.5mM CoCl2 for 6h whole cell lysate at 20 µg
Lane 4:
HeLa treated with 0.5mM DFO for 24h whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 110 kDa
false
- ChIC/CUT&RUN-seq
Supplier Data
ChIC/CUT&RUN sequencing - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2.5 x 10^5 HeLa (Human cervix adenocarcinoma epithelial cell line) cells treated with Cocl2 (500 μM 20h+4h) and MG-132 (10µM 4h) and 5 µg of ab51608 [EP1215Y]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. Additional screenshots of mapped reads can be found in the Protocol booklet in the Product Protocol section. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
CUT&RUN was performed using the ChIC/CUT&RUN pAG-MNAse ab285373, 2.5 x 10^5 HeLa cells, and 5μg of ab51608 [EP1215Y]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. Additional screenshots of mapped reads can be downloaded here.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
Immunohistochemical analysis using unpurified ab51608 showing positive staining in Colonic adenocarcinoma tissue. Heat mediated antigen retrieval was performed via the microwave method before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
Immunohistochemical analysis using unpurified ab51608 showing positive staining in Breast carcinoma tissue.
- WB
Supplier Data
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
All lanes:
Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) at 1/100 dilution
All lanes:
Ramos Cells treated with Cocl2 at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), HRP- conjugated at 1/1000 dilution
Predicted band size: 92 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-HIF-1 alpha antibody [EP1215Y] (AB51608)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
関連する標識済み抗体及び組成の異なる製品 (2)
-
Anti-HIF-1 alpha antibody [EP1215Y] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-HIF-1 alpha antibody [EP1215Y]
Reactivity data
製品の詳細
Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ChIC/CUT&RUN-seq, Flow Cyt (Intra), ICC/IF, IHC-P, IP, WB in human samples.
Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) has been cited over 340 times in peer reviewed journals and is trusted by the scientific community.
Abcams high quality manufacturing and validation processes ensure Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) has been confirmed by testing in knockout samples.
Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) has 12 independent reviews from customers.
Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) specifically detects HIF-1 alpha (UniProt ID: Q16665; Molecular weight: 93kDa) and is sold in 100 uL and 1 mL selling sizes.
Conjugation-ready, carrier free format available for antibody clone EP1215Y - ab2173.
Antibody clone EP1215Y is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 647 (ab19569).
HIF-1 alpha, also known as hypoxia-inducible factor 1-alpha (HIF1A), is a critical regulator of cellular response to low oxygen levels. HIF1A is a transcription factor commonly referred to as a "master regulator of the hypoxic response" for its central role in the regulation of cellular adaptations to hypoxia. Hypoxia contributes to the pathophysiology of human disease, including myocardial and cerebral ischemia, cancer, pulmonary hypertension, congenital heart disease and chronic obstructive pulmonary disease. A highly specific HIF-1 alpha antibody, essential for studying hypoxia-inducible factors and oxygen homeostasis. This antibody is crucial in tumor hypoxia research, particularly in understanding cancer progression and angiogenesis. It is widely used in studies of metastasis and HIF-1 alpha inhibitors. The HIF1A molecular weight is approximately 120 kDa, and detecting it accurately is essential for understanding its role in the tumor microenvironment. Elevated HIF-1 alpha levels are linked to tumor progression, angiogenesis, and metastasis. Monitoring HIF-1 alpha can provide valuable insights into cancer biology and potential therapeutic targets. This antibody is also validated for CUT&RUN-seq, which is a key application to map protein-DNA interactions on a genome-wide scale using NGS.
For Mouse specific Hif-1-alpha rabbit monoclonal antibody, please see ab179483 (clone ID: EPR16897).
ab179483 has been confirmed for Mouse sample in WB.
We have mixed customer feedback towards the rat specificity so we are unable to confirm and guarantee its performance with rat samples. Please contact technical team for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HIF-1 alpha regulates gene expression in response to hypoxic conditions in cells. It forms a complex with HIF-1 beta to activate transcription of various genes involved in energy metabolism angiogenesis and erythropoiesis. HIF-1 alpha enables cells to adapt to reduced oxygen availability allowing for cellular survival and function under stress. It plays an important role in promoting the expression of genes like VEGF and EPO which are important for vascular and red blood cell development respectively.
Pathways
HIF-1 alpha plays an integral role in the hypoxia signaling pathway and the glycolytic pathway. In the hypoxia signaling pathway HIF-1 alpha partners with VHL (Von Hippel-Lindau) protein that regulates its degradation under normal oxygen conditions. When oxygen levels drop HIF-1 alpha avoids degradation stabilizes and translocates into the nucleus to initiate transcription of hypoxia-responsive genes. The glycolytic pathway involvement highlights its function in adapting energy production under hypoxic conditions through collaboration with enzymes and transporters associated with glycolysis.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
- Download chicCutRunSequencingBooklet|en
ターゲットの情報
文献 (450)
Recent publications for all applications. Explore the full list and refine your search
International journal of biological sciences 21:5411-5427 PubMed40959276
2025
Applications
Unspecified application
Species
Unspecified reactive species
Balkan medical journal 42:440-451 PubMed40888349
2025
Applications
Unspecified application
Species
Unspecified reactive species
Antioxidants (Basel, Switzerland) 14: PubMed40867888
2025
Applications
Unspecified application
Species
Unspecified reactive species
Discover oncology 16:1638 PubMed40864330
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:542 PubMed40691131
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 29:e70703 PubMed40629256
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:6261 PubMed40623999
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 23:653 PubMed40514690
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:4681 PubMed40394007
2025
Applications
Unspecified application
Species
Unspecified reactive species
ACS omega 10:17584-17594 PubMed40352542
2025
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com